Toggle Offcanvas
...
 
Dapagliflozin Tenders

Dapagliflozin Tenders

View Dapagliflozin tenders, RFPs and contracts. Bid on readily available Dapagliflozin tenders with the best and most comprehensive tendering platform, since 2002.
Dapagliflozin is a medication used to lower blood sugar levels in people with type 2 diabetes. It works by helping the kidneys remove excess glucose from the body through urine, making it easier to control blood sugar levels.

Bidding for Dapagliflozin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Dapagliflozin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Dapagliflozin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Dapagliflozin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

31 Live Notices for Dapagliflozin Tenders

Showing 1 to 20

Object: Electronic Auction - Formation Of Price Record Minutes For The Occasional Supply Of Medicines - Miscellaneous Group 16.
country Brazil
posting date18 Oct 2025
deadline01 Nov 2025
Supply of Drugs - ZN Dapagliflozin (Generic)
country Qatar
posting date17 Oct 2025
deadline10 Nov 2025
Object: Electronic Auction - Acquisition Of General Solid Medicines I For The University Hospital Of The Federal University Of Roraima
country Brazil
posting date17 Oct 2025
deadline31 Oct 2025
Object: Electronic Auction - Acquisition Of Pharmacological And Hospital Material For The 4Th Rcc And Oms Of Gcalc.
country Brazil
posting date17 Oct 2025
deadline31 Oct 2025
Object: Electronic Auction - Recording Of Prices For Eventual And Future Acquisition Of Medicines From The Basic Pharmacy (Remaining Items)
country Brazil
posting date16 Oct 2025
deadline30 Oct 2025
Object: Electronic Auction - Aims At Price Registration For The Provision Of Legal Action - Glifage, Xigduo, Forxiga, Januvia, Sitagliptin, Linagliptin And Empagliflozin
country Brazil
posting date16 Oct 2025
deadline30 Oct 2025
Object: Electronic Auction - Price Registration Good Consumption - Acquisition Of Medicines - Court Order
country Brazil
posting date15 Oct 2025
deadline29 Oct 2025
Object: Electronic Auction - Price Registration For Future Purchase Of Medicines - Legal Demand 35. Protocol Nº 24.310.316-9
country Brazil
posting date11 Oct 2025
deadline25 Oct 2025
Object: Electronic Auction - Price Registration, Aiming At The Acquisition Of Medicines From Group 2 Of The Specialized Component Of Pharmaceutical Assistance Ceaf, Regulated By Consolidation Ordinance No. 6, Of September 28, 2017, Title V, Chapter Ii, To Meet The Needs Of The Superintendence Of Pharmaceutical Assistance Suaf, Linked To The State Health Department Of The State Of Maranhão - Ses.
country Brazil
posting date10 Oct 2025
deadline24 Oct 2025
Completion Of Non-Exclusive Discount Agreements According To Section 130A (8) Sgb V On The Active Ingredients Mentioned With A Final Option In The Context Of The So-Called Open House Process.
country Germany
posting date07 Oct 2025
deadline31 Dec 2026
Open House Original Discount Contracts 2025-20 - Metformin/Dapagliflozin (Combination Of Active Ingredients)
country Germany
posting date20 May 2025
deadline31 Jul 2027
Open House Original Discount Contracts 2025-20 - Metformin/Dapagliflozin (Combination Of Active Ingredients)
country Germany
posting date20 May 2025
deadline31 Jul 2027
Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Dec 2024
deadline02 Dec 2026
Medicines Containing The Active Ingredient Dapagliflozin (Atc: A10Bk01)
country Germany
posting date27 Aug 2024
deadline31 Jul 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin + Metformin, Atc A10Bd15 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date19 Aug 2024
deadline05 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date19 Aug 2024
deadline05 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date17 Aug 2024
deadline05 Aug 2026
Transitional Drugs 5
country United Kingdom
posting date06 Oct 2025
deadline06 Oct 2026
Nhs National Transition Framework For Apremilast, Pazopanib And Dapagliflozin
country United Kingdom
posting date04 Sep 2025
deadline03 Sep 2026
Glucose Solution For Injection 40 % Of 20 Ml (Glucose), Dapagliflozin Tablets Covered With A Film Sheath, 10 Mg (Dapagliflozin), Dexamethasone, Solution For Injection Of 4 Mg/Ml Doxycycline Capsules/100 Mg Tablets (Doxycycline), . Still
country Ukraine
posting date13 Oct 2025
deadline28 Oct 2025

Share Share this page